Shay Capital’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$603K Sell
205,114
-29,823
-13% -$132K 0.05% 238
2025
Q4
$1.17M Sell
234,937
-54,608
-19% -$238K 0.12% 166
2025
Q3
$912K Sell
289,545
-3,102
-1% -$8.51K 0.08% 185
2025
Q2
$661K Buy
292,647
+26,913
+10% +$76.7K 0.08% 152
2025
Q1
$710K Buy
265,734
+240,734
+963% +$749K 0.1% 114
2024
Q4
$88K Sell
25,000
-425,000
-94% -$1.93M 0.01% 281
2024
Q3
$2.13M Hold
450,000
0.3% 53
2024
Q2
$2.12M Hold
450,000
0.29% 65
2024
Q1
$2.05M Sell
450,000
-275,000
-38% -$1.22M 0.32% 55
2023
Q4
$2.99M Sell
725,000
-16,000
-2% -$69.7K 0.6% 38
2023
Q3
$3.19M Sell
741,000
-35,600
-5% -$179K 0.45% 42
2023
Q2
$4.03M Buy
776,600
+296,600
+62% +$2.08M 0.56% 30
2023
Q1
$3.26M Buy
480,000
+140,000
+41% +$665K 0.64% 25
2022
Q4
$833K Hold
340,000
0.26% 80
2022
Q3
$1.12M Sell
340,000
-55,759
-14% -$266K 0.24% 80
2022
Q2
$1.93M Sell
395,759
-5,609
-1% -$38K 0.39% 55
2022
Q1
$3.04M Sell
401,368
-4,349
-1% -$32.4K 0.39% 32
2021
Q4
$3.16M Buy
405,717
+25,427
+7% +$200K 0.52% 35
2021
Q3
$3.23M Sell
380,290
-22,785
-6% -$179K 0.42% 51
2021
Q2
$3.62M Buy
403,075
+268,075
+199% +$2.55M 0.42% 42
2021
Q1
$1.56M Buy
+135,000
New +$1.6M 0.16% 125

Other funds holding ACHV

Shay Capital's ACHV Position: Q1 2026 in Review

Shay Capital reduced its Achieve Life Sciences (ACHV) stake by 13% in Q1 2026, selling an estimated $132K and leaving 205,114 shares worth $603K. The position accounts for 0.05% of the portfolio, ranked #238.

Shay Capital first reported a position in ACHV in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.03M in Q2 2023. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Shay Capital held 205,114 shares of Achieve Life Sciences worth $603K as of Q1 2026.
  • Shay Capital sold 29,823 Achieve Life Sciences shares in Q1 2026, an estimated $132K.
  • Achieve Life Sciences made up 0.05% of Shay Capital's portfolio in Q1 2026, its #238 holding.
  • Shay Capital first reported a position in Achieve Life Sciences in Q1 2021 and has held it in 21 quarters since.
  • Shay Capital's Achieve Life Sciences position peaked at $4.03M in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.